Abstract
Alzheimer's disease (AD), the neurodegenerative disorder with the highest prevalence among cases of dementia in the world, is characterized by functional and cognitive decline, with emphasis on memory loss. The current treatment involves acetylcholinesterase inhibitors that causes significant adverse effects such as nausea, vomiting and liver toxicity. Thus, alternatives to the treatment …